Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00000822 |
|---|---|
| Brief Title: | A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells |
| First Submitted : | November 2, 1999 |
| First Submitted that Met QC Criteria : | August 30, 2001 |
| First Posted : | August 31, 2001 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 27, 2021 |
| Last Update Posted : | October 29, 2021 |